From the latest Edison report.
"Depending on trial progress and the timing of milestone payments from partners, Immutep may require additional funding to complete the efti clinical trials; our diluted valuation of 12c per share does not include the potential dilution from any future capital raising.
Ann: Trading Halt, page-14
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
-0.033(9.15%) |
Mkt cap ! $475.7M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 31.5¢ | $2.043M | 6.213M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 333445 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 188049 | 17 |
View Market Depth
| Last trade - 15.08pm 15/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |